Journal of Medicinal Chemistry 1992-05-15

HIV-1 protease inhibitors based on hydroxyethylene dipeptide isosteres: an investigation into the role of the P1' side chain on structure-activity.

S D Young, L S Payne, W J Thompson, N Gaffin, T A Lyle, S F Britcher, S L Graham, T H Schultz, A A Deana, P L Darke

Index: J. Med. Chem. 35 , 1702, (1992)

Full Text: HTML

Abstract

A systematic investigation was undertaken to determine the role of the P1' sidechain in a series of hydroxyethylene isostere based inhibitors of HIV-1 protease. Substitution and homologation of the benzyl P1' side chain of the Phe-Phe isostere based pseudo peptides 1 (L-682,679) and 2 (L-685,434) with various heteroalkyl groups leads to a series of extremely potent inhibitors of the enzyme. Several examples of the most potent inhibitors were very effective in an ex vivo cell based viral spread assay using human H9 T-lymphocytes and the IIIb isolate of HIV-1. Compound 19 is 120 times more potent than 1 and 16 times more potent than 2 in inhibiting the spread of infection in this assay.

Related Compounds

Structure Name/CAS No. Articles
(1R,2S)-1-Amino-2,3-dihydro-1H-inden-2-ol Structure (1R,2S)-1-Amino-2,3-dihydro-1H-inden-2-ol
CAS:136030-00-7